# Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

> **NCT02534649** · NA · RECRUITING · sponsor: **Institut Bergonié** · enrollment: 10000 (estimated)

## Conditions studied

- Solid Tumor
- Hematological Malignancy

## Interventions

- **PROCEDURE:** Newly obtained biopsy and Blood samples collection

## Key facts

- **NCT ID:** NCT02534649
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-12
- **Primary completion:** 2028-03
- **Final completion:** 2029-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02534649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02534649, "Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02534649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*